Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer

K. Otsubo, N. Seki, Y. Nakanishi, I. Okamoto

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)780-781
Number of pages2
JournalAnnals of Oncology
Volume29
Issue number3
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Meningeal Carcinomatosis
Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Brain
pembrolizumab

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this

Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer. / Otsubo, K.; Seki, N.; Nakanishi, Y.; Okamoto, I.

In: Annals of Oncology, Vol. 29, No. 3, 01.03.2018, p. 780-781.

Research output: Contribution to journalLetter

@article{10fd73b98c92488f8961c57f8880780e,
title = "Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer",
author = "K. Otsubo and N. Seki and Y. Nakanishi and I. Okamoto",
year = "2018",
month = "3",
day = "1",
doi = "10.1093/annonc/mdx700",
language = "English",
volume = "29",
pages = "780--781",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer

AU - Otsubo, K.

AU - Seki, N.

AU - Nakanishi, Y.

AU - Okamoto, I.

PY - 2018/3/1

Y1 - 2018/3/1

UR - http://www.scopus.com/inward/record.url?scp=85046087105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046087105&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx700

DO - 10.1093/annonc/mdx700

M3 - Letter

C2 - 29088405

AN - SCOPUS:85046087105

VL - 29

SP - 780

EP - 781

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 3

ER -